Detailed answers about HICORE LIFE SCIENCES LIMITED, including incorporation, status, business activity, and accounts information.
When was HICORE LIFE SCIENCES LIMITED founded?
HICORE LIFE SCIENCES LIMITED was officially incorporated on 14 April 2026 and is registered under company number 17155680. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is HICORE LIFE SCIENCES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of HICORE LIFE SCIENCES LIMITED?
HICORE LIFE SCIENCES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does HICORE LIFE SCIENCES LIMITED do?
HICORE LIFE SCIENCES LIMITED operates in the following sectors: 46190 - Agents involved in the sale of a variety of goods, 46460 - Wholesale of pharmaceutical goods, 47910 - Retail sale via mail order houses or via Internet, 72110 - Research and experimental development on biotechnology. These SIC codes provide insight into the company's business activities and industry focus.
What is HICORE LIFE SCIENCES LIMITED's registered address?
The registered office address of HICORE LIFE SCIENCES LIMITED is L220, Beaconside Business Village,, Stafford Enterprise Park,Weston Road,, Stafford,, United Kingdom, ST18 0BF. This is the official address filed with Companies House for legal and statutory correspondence.
Is HICORE LIFE SCIENCES LIMITED financially stable?
Financial accounts for HICORE LIFE SCIENCES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.